Company Information
CIN
Status
Date of Incorporation
18 February 2013
State / ROC
Hyderabad / ROC Hyderabad
Industry
Sub Category
Non-govt company
Last Balance Sheet
Last Annual Meeting
Paid Up Capital
10,000,000
Authorised Capital
10,000,000
Directors
Past Directors
Patents
The present invention relates to improved and novel processes for the preparation of 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}- N-(methylsulfonyl) acetamide of formula-1, which is represented by the following structural formula:
Abstract
The present invention relates to novel crystalline form of 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy} - N-(methylsulfonyl) acetamide compound of formula-1 and process for. the preparation thereof.
The present invention relates to an improved process for the preparation of N-[(4-fluorophenyl) methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxa diazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide monopotassium salt compound of formula-1a, which is represented by the following s...
The present invention relates to amorphous MTBE solvate of Tigecycline compound of formula-1 and process for preparation thereof.
The present application relates to an improved process for the preparation of
10 Ozanimod, its salts and intermediates thereof. which is represented by the following
structural formula-1.
The present application relates to an improved and novel process for the preparation
of docosanol, which is represented by the following structural formula-1.
5
Formula-1
The present invention relates to novel crystalline form of 2-{4-[(5,6-diphenylpyrazin-2- yl)(isopropyl)amino]butoxy}- N-(methylsulfonyl) acetamide compound of formula-1, which is represented by the following structural formula:
Formula-1
The present application relates to a process for the preparation of Carbimazole, which
5 is represented by the following structural formula-1.
Formula-1
The present invention relates to an improved process for the preparation of 2-chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide compound of formula-1, which is represented by the following structural formula:
Formula-1
The present invention relates to a crystalline form of 1-cyclopropyl-8-methyl-7-(5-
methyl-6-(methylamino)pyridin-3-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
compound of formula-1, which is represented by the following structural formula. The present
invention also relates to process for the preparation cr...
The present application relates to process for the preparation of Netarsudil
dimesylate, its pharmaceutically acceptable salts, and intermediates thereof, which is
represented by the following structural formula-I.
10
Formula-I
The present application relates to an improved process for the preparation of
Divalproex sodium, which is represented by the following 10 structural formula-1.
Formula-1
The present application relates to an improved and novel process for the preparation
of Varenicline Tartrate, which is represented by the following 10 structural formula-1.
Formula-1
15
TITLE OF THE INVENTION : A process for the preparation of Deutetrabenazine and
5 intermediates thereof.
The present application relates to a process for the preparation of deutetrabenazine,
and intermediates thereof; which is represented by the following structural formula-I.
Title of the invention : An improved process for the preparation of Besifloxacin
5 Hydrochloride and intermediates thereof.
The present application relates to an improved process for the preparation of
Besifloxacin hydrochloride and intermediates thereof, which is represented by the following
structural formula-...
TITLE OF THE INVENTION : A process for the preparation of Ozanimod
Hydrochloride and intermediates thereof;
10
The present application relates to a process for the preparation of Ozanimod
Hydrochloride, and intermediates thereof. which is represented by the following structural
formula-1a.
15
Formula-1a
...
Abstract
5
The present application relates to an improved process for the preparation of
Penciclovir, and intermediates thereof; which is represented by the following structural
formula-I.
10
Formula-I
Abstract
The present application relates to an improved process 5 for the preparation of
Lercanidipine Hydrochloride and intermediates thereof, which is represented by the
following structural formula-1.
10
Formula-1
TITLE OF THE INVENTION: An improved process for the preparation of Levodopa.
10
The present application relates to an improved process for the preparation of
Levodopa, which is represented by the following structural formula-I.
15
Formula-I
The present invention relates to a crystalline form of N-ethyl-1-(3-(trifluoro methyl) phenyl)
propan-2-amine hydrochloride compound of formula-1, which is represented by the following
structural formula. The present invention also relates to process for the preparation of compound
of formula-1.
10
Formula-1
...
TITLE OF THE INVENTION: A process for the preparation of Siponimod hemi
fumaric acid and intermediates thereof
5
The present application relates to a process for the preparation of Siponimod hemi
fumaric acid and intermediates thereof, which is represented by the following structural
formula-I.
...
TITLE OF THE INVENTION : An efficient process for nicotinic receptor
agonist, varenicline tartrate salt;
10 The present application relates to an improved process for the preparation of
Varenicline tartrate free form nitroso impurities, which is represented by the following
structural formula-1.
15
Formula-1
...
TITLE OF THE INVENTION : A process for the preparation of raltegravir
10 potassium and its intermediates thereof.
The present invention relates to a process for the preparation of N-[(4-fluorophenyl)
methyl]-1,6-dihydro5-
hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)
carbonyl] amino]ethyl]-6-...
TITLE OF THE INVENTION: Crystalline forms of Netarsudil dimesylate and process for
preparation thereof;
10
The present application relates to polymorphs of Netarsudil dimesylate salt and process
thereof, which is represented by the following structural formula-I.
15
Formula-I
TITLE OF THE INVENTION: A process for the preparation of 1,3-Dihydro-1-methyl-
2H-imidazole-2-thione
The present application relates to a process for the preparation of Methimazole, which
10 is represented by the following structural formula-1.
15 Formula-1
TITLE OF THE INVENTION :
A process for the preparation of Esketamine hydrochloride and intermediates thereof
10
The present application relates to a process for the preparation of Esketamine
hydrochloride and intermediates thereof, which is represented by the following structural
formula-I.
15
Formula-I.
...
TITLE OF THE INVENTION:
10 Polymorphs of 5-(3-{(1S)-1-[(2-hydroxyethyl)amino]-2,3-dihydro-1H-inden-4-yl}-1,2,4-
oxadiazol-5-yl)-2[(propan-2-yl)oxy]benzonitrile Hydrochloride and process for preparation
thereof.
15 The present invention relates to novel crystalline form of 5-(3-{(1S)-1-[(2-
hydroxyethyl)amino]-2...
TITLE OF THE INVENTION: A process for preparation of finerenone and
intermediates thereof.
The present application relates to an improved process for the preparation of finerenone and intermediates thereof, which is represented by the following structural
formula-I.
Abstract
TITLE OF THE INVENTION: A process for preparation of Viloxazine Hydrochloride and intermediates thereof.
The present application relates to an improved process for the preparation of Viloxazine Hydrochloride and its intermediate’s thereof, represented by the following structural formula-I.
...
Abstract
TITLE OF THE INVENTION: A process for preparation of Ospemifene and intermediates thereof.
The present application relates to an improved process for the preparation of Ospemifene, and intermediate’s thereof, represented by the following structural formula-I.
Formul...
TITLE OF THE INVENTION : An improved process for Vonoprazan Fumarate and intermediates thereof
The present application relates to an improved process for the preparation of Vonoprazan fumarate, and intermediates thereof, which is represented by the following structural formula-I.
...
Abstract
TITLE OF THE INVENTION: An improved process for finerenone and intermediates thereof.
The present application relates to an improved process for the preparation of finerenone and intermediates thereof, is represented by the following structural formula-I.
...
Abstract
TITLE OF THE INVENTION : An improved process for Mitapivat sulfate and intermediates thereof;
The present application relates to an improved process for the preparation of Mitapivat sulfate, and intermediates thereof, which is represented by the following structural formula-I.
Formula-...
Abstract
TITLE OF THE INVENTION: Polymorphs for Mitapivat sulfate and processes thereof
The present application relates to novel crystalline forms for Mitapivat sulfate and processes thereof, is represented by the following structural formula-I.
Abstract
TITLE OF THE INVENTION: An improved process for [(1R)-1-(2-Chlorophenyl)-2- (tetrazol-2-yl) ethyl] carbamate
The present application relates to an improved process for the preparation of cenobamate, is represented by the following structural formula-I.
TITLE OF THE INVENTION: Process for 2-(1-Methylethyl)-5-[(1E)-2- phenyl ethenyl]-1,3-benzenediol and polymorphs thereof
The present invention relates to process for 2-(1-Methylethyl)-5-[(1E)-2-phenyl ethenyl]-1,3-benzenediol and polymorphs and intermediates thereof, which is represented by the following str...
Abstract
TITLE OF THE INVENTION: An improved process for (2R,3S)-2-[4-(Cyclopentyl amino) phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]-3-piperidine carboxamide and intermediates thereof .
The present application relates to an improved process for the preparation of avacopan a...
Abstract
TITLE OF THE INVENTION: An improved process for methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl] pyrimidin-5-yl} carbamate and intermediates thereof.
The present application relates to an improved process for the preparation of vericiguat, which is represented by...
Abstract
TITLE OF THE INVENTION: Crystalline form of Mitapivat sulfate hydrate and processes thereof
The present application relates to crystalline form of Mitapivat sulfate hydrate and process thereof, is represented by the following structural formula-I.
Abstract
TITLE OF THE INVENTION: An improved process for 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- 2,4(1H,3H)- pyrimidinedione and intermediates thereof
The present invention relates to an improved process for preparation of 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- 2,4(1H,3H)- pyrimidinedio...
Abstract
TITLE OF THE INVENTION: An improved process for N-((1s,3s)-3-(methyl(7H-pyrrolo [2,3-d]pyrimidin-4-yl)amino) cyclobutyl)propane-1-sulfonamide and intermediates thereof
The present application relates to an improved process for abrocitinib and intermediates thereof, is represented by the following...
Abstract
5
TITLE OF THE INVENTION: An alternative process for (3R)-7-[[4-cyclopentyl-3-(trifluoro
methyl) phenyl] methoxy]-1,2,3,4- tetra hydrocyclopent [b]indole-3-acetate, L-Arginine and
intermediates thereof.
10
The present application relates to an alternative process for Etrasimod L-Arginine and intermedi...
Abstract
TITLE OF THE INVENTION: An alternative process for (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl] propanoic acid and intermediates thereof.
The present application relates to an alternative process for (2S)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl] propanoic acid and intermediates thereof...
TITLE OF THE INVENTION: An improved process for (S)-7-((5, 7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamide and intermediates thereof
The present application relates to an improved process for tegoprazan and intermediates thereof, represented by the following structural formula-I.
...
